• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, SA ETEST® MEROPENEM MP 32 WW B30

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, SA ETEST® MEROPENEM MP 32 WW B30 Back to Search Results
Catalog Number 513800
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Patient Involvement (2645)
Event Type  malfunction  
Event Description
A customer in (b)(6) reported a false susceptible meropenem result for a klebsiella pneumoniae external quality control sample ((b)(4), specimen (b)(6)) in association with etest® meropenem mp 32 ww b30.The customer repeated the etest three times and reported a susceptible (mic=1.5) result, when the expected was resistant.(mc=16).The isolate was also tested on the vitek® ast-n350 card in which meropenem was resistant (mic>=16).There was no patient involvement as the event pertained to a quality survey sample.A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
An internal investigation was performed for a false susceptible meropenem result for a klebsiella pneumoniae external quality control sample (uk neqas distribution 4297, specimen 4431) in association with etest® meropenem mp 32 ww b30.Biomérieux investigated the retained samples of lot 1004872950.The conformity of lot 1004872950, and an internal reference lot 1006887150 was confirmed with the atcc quality control strains tested for the release of this reference: atcc (b)(6) escherichia coli, atcc (b)(6) enterococcus faecalis, atcc (b)(6) streptococcus pneumoniae, atcc (b)(6) pseudomonas aeruginosa, atcc (b)(6) haemophilus influenzae, atcc (b)(6) bacteroides fragilis.A complain trend analysis confirmed there was no other complaint registered on the lot.The identification of the neqas strain to klebsiella pneumoniae was confirmed with vitek ms methodology.The neqas strain was tested with the etest mp 32 lot 1004872950 mentioned by the customer, and an internal reference lot 1006887150.The results obtained with two lots were >32 g/ml, categorized as resistant based on eucast breakpoints.Conclusion: the susceptible result obtained with etest mp 32, lot 1004872950, by the customer was not reproduced in-house.The results obtained with etest meropenem mp 32, lot 1004872950, and the atcc quality control strains tested during the investigation conformed with specifications.Etest results on the neqas strain was correlated to expected result for meropenem: resistant.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ETEST® MEROPENEM MP 32 WW B30
Type of Device
ETEST® MEROPENEM MP 32 WW B30
Manufacturer (Section D)
BIOMERIEUX, SA
3 route de port michaud
la balme, les grottes isere 38390
FR  38390
MDR Report Key8087135
MDR Text Key129331356
Report Number3002769706-2018-00243
Device Sequence Number1
Product Code JWY
Combination Product (y/n)N
PMA/PMN Number
K010363
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 02/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/19/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/20/2019
Device Catalogue Number513800
Device Lot Number1004872950
Was Device Available for Evaluation? No
Date Manufacturer Received01/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-